Related Experiment Video
Updated: Jul 6, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Cell replacement therapy for intracerebral hemorrhage
Robert H Andres1, Raphael Guzman, Angélique D Ducray
1Department of Neurosurgery, Stanford University Medical Center, Stanford, California, USA.
Insights
Developing new treatments for intracerebral hemorrhage (ICH) is critical. Promising strategies include cell replacement, boosting the brain
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stroke Research
Background:
- Intracerebral hemorrhage (ICH) is a severe stroke type with no effective treatments.
- Developing new therapeutic options for ICH is a significant medical challenge.
Purpose of the Study:
- To review recent advances in basic science for intracerebral hemorrhage treatment strategies.
- To explore promising therapeutic avenues for ICH.
Main Methods:
- Review of experimental data on cell transplantation for functional recovery.
- Investigation of methods to activate endogenous repair mechanisms (growth factors, inhibitory molecule inactivation).
- Evaluation of neuroprotective drugs for neuronal survival in the perihematomal area.
Main Results:
- Cell transplantation shows promise for functional recovery after ICH.
- Activating endogenous repair mechanisms is a key research focus.
- Neuroprotective drugs offer potential for improving neuronal survival.
Conclusions:
- Cell replacement, enhancing endogenous repair, and neuroprotection are promising ICH therapies.
- Further research is needed to address scientific challenges before clinical translation.
- This review highlights key advances in ICH treatment strategies.
Abstract:
Intracerebral hemorrhage (ICH), for which no effective treatment strategy is currently available, constitutes one of the most devastating forms of stroke. As a result, developing therapeutic options for ICH is of great interest to the medical community. The 3 potential therapies that have the most promise are cell replacement therapy, enhancing endogenous repair mechanisms, and utilizing various neuroprotective drugs. Replacement of damaged cells and restoration of function can be accomplished by transplantation of cells derived from different sources, such as embryonic or somatic stem cells, umbilical cord blood, and genetically modified cell lines. Early experimental data showing the benefits of cell transplantation on functional recovery after ICH have been promising. Nevertheless, several studies have focused on another therapeutic avenue, investigating novel ways to activate and direct endogenous repair mechanisms in the central nervous system, through exposure to specific neuronal growth factors or by inactivating inhibitory molecules. Lastly, neuroprotective drugs may offer an additional tool for improving neuronal survival in the perihematomal area. However, a number of scientific issues must be addressed before these experimental techniques can be translated into clinical therapy. In this review, the authors outline the recent advances in the basic science of treatment strategies for ICH.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Ischemic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
